Plasma Disc Decompression Versus Conservative Care

NCT ID: NCT00940810

Last Updated: 2015-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-08-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the plasma disc decompression (PDD) procedure to conservative care (physiotherapy) for the treatment of patients with radicular pain originating from a disc protrusion. Treatment efficacy and rate of improvement is evaluated at 8 weeks after treatment start and followed-up for 1 year after treatment start.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Decompression, Surgical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PDD procedure

Group Type EXPERIMENTAL

Plasma Disc Decompression/Nucleoplasty

Intervention Type PROCEDURE

Subjects assigned to the PDD Group will be scheduled to receive the plasma disc decompression procedure using the Coblation® method.

Similarly to in Conservative Care group, subjects will be followed-up at 2, 8 weeks, 6 and 12 months (calculated from the date of the PDD procedure). The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.

Conservative Care

Group Type ACTIVE_COMPARATOR

Conservative Care (physiotherapy)

Intervention Type PROCEDURE

Subjects assigned to the Conservative Care Group will be scheduled to receive physical therapy according to standard and customary care locally.

Subjects will be followed-up at 2, 8 weeks, 6 and 12 months . (Calculated from the time of first going through the individual training programme).The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plasma Disc Decompression/Nucleoplasty

Subjects assigned to the PDD Group will be scheduled to receive the plasma disc decompression procedure using the Coblation® method.

Similarly to in Conservative Care group, subjects will be followed-up at 2, 8 weeks, 6 and 12 months (calculated from the date of the PDD procedure). The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.

Intervention Type PROCEDURE

Conservative Care (physiotherapy)

Subjects assigned to the Conservative Care Group will be scheduled to receive physical therapy according to standard and customary care locally.

Subjects will be followed-up at 2, 8 weeks, 6 and 12 months . (Calculated from the time of first going through the individual training programme).The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient has one symptomatic contained, focal herniated lumbar disc.
2. Patient's age should be at least 18 years old and no more than 65 years old.
3. A VAS score for radicular pain of 50 or greater on a scale of 0 to 100.
4. Radicular pain concordant with image findings (MRI/CT not older than 12 months).
5. Disc height greater or equal to 50% of expected height in the range of a patient's normal anatomic variations and expected changes due to age.
6. Patient signs informed consent.

Exclusion Criteria

1. Patient is pregnant, or pregnancy is suspected or planned within the study timeframe.
2. Patient has a cardiac pacemaker, automatic defibrillator, or any peripheral stimulator leads in the lumbar area.
3. Allergy to contrast media or drugs to be used in the intended procedure.
4. Medical co-morbidities that preclude surgical intervention.
5. Patient is receiving anti-psychotic therapy.
6. Patient is a prisoner.
7. Patient is incapable of understanding or responding to the study questionnaires.
8. History of previous spinal surgery at, or directly adjacent to, the level to be treated.
9. Patient is morbidly obese (BMI ≥ 40).
10. Patient is simultaneously participating in another device or drug study related to limb/axial pain.
11. Patient has a spinal fracture, tumor or infection.
12. Radicular pain originating from more than one disc level.
13. Axial (back) pain greater than radicular (leg) pain.
14. Clinical evidence of cauda equina syndrome.
15. Progressive neurologic deficit.
16. Radiological evidence of spondylolisthesis at the level to be treated.
17. Radiological evidence of moderate/severe stenosis at the level to be treated.
18. Evidence of extruded or sequestered disc herniation on magnetic resonance imaging.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ArthroCare Corporation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Raahe Hospital

Raahe, , Finland

Site Status

Storängskliniken

Stockholm, , Sweden

Site Status

Pallium Reseach Group; Pain Management, L Ward Seacroft Hospital

Leeds, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland Sweden United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PDDCC-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.